Emergency BU Alert BU Medical Campus OPEN Jan. 28, 2015 Boston University Medical Campus will be open Wednesday, Jan. 28, 2015. BUSM classes will be held as scheduled. Staff should check with their managers regarding work schedules. Medical, PA and GMS students who are assigned to inpatient services or clinics are expected to be present, if possible. Students who are assigned to outpatient services should check with their course director or the policy at the clinical site. GMS classes are canceled. Staff should check with their manager regarding their work schedules. The Henry M. Goldman School of Dental Medicine will follow normal school hours. All Patient Treatment Centers will be open for patient care and all classes will be held as scheduled. BU School of Public Health classes are canceled; SPH non-essential staff may telecommute. Employees who are part of the BUMC parking program should park in your assigned lot or garage. The Boston parking ban is still in effect. For updated information, please call the weather/emergency hotline at 617-638-6886 or visit the BU Emergency Communications website at http://www.bu.edu/ehs/comm/

Sullivan, Meg, M.D.

Medical School: Loyola University Stritch School of Medicine
Residency training: Brigham and Women’s Hospital
Fellowship training: Johns Hopkins University

Dr. Meg Sullivan is the Medical Director of the Center for Infectious Diseases at Boston Medical Center (BMC).  The clinic is comprised of the HIV/Primary Care Clinic, the Travel/International Health Clinic, the STD Clinic and a specialty service for consultation in Infectious Diseases.  In her role as director of clinic HIV activities she has focused on models for successful engagement and retention of HIV positive patients into ongoing medical care.  She is the principal investigator of several studies implemented in the clinic related to this theme funded by the CDC, HRSA and the NIH in close collaboration with her colleagues at the BU School of Public Health.

Additionally, she has nearly twenty years of experience in the field of the reproductive health of HIV-affected patients including investigating methods to reduce HIV transmission risk in serodiscordant couples desiring conception.  She was the principal investigator of the ARTEMIS (Assisted Reproduction Treatment and Education Models In Serodiscordants) study assessing the feasibility and acceptability of sperm wash and IUI in HIV-infected males with HIV negative female partners.  She has recently been funded to investigate the use of PrEP (pre-exposure prophylaxis) for conception in serodiscordant couples.



Primary teaching affiliate
of BU School of Medicine